LINC01878

Across TCGA pan-cancer cohorts, LINC01878 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated LINC01878 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher LINC01878 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC01878 expression acts as an unfavorable survival marker, although some lineages such as THCA and CESC show a favorable association.

LUAD, LIHC, and STAD are the cancer types where LINC01878 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Tertile	II,III,IV	0.452	0.713	<.001	114	view →
LIHC	OS	Tertile	II,III,IV	0.105	0.720	<.001	81	view →
STAD	DFS	Tertile	II,III,IV	0.534	0.677	.005	62	view →
UVM	OS	Tertile	All	0.220	0.917	<.001	54	view →
THCA	OS	Median	III,IV	1.000	0.722	<.001	48	view →
SKCM	DFS	Tertile	IV	0.036	0.433	<.001	45	view →
CESC	OS	Tertile	All	0.895	0.771	.020	42	view →
READ	DFS	Tertile	II,III,IV	0.111	0.800	.001	27	view →
OV	DFS	Quartile	IV	0.306	0.506	.015	26	view →
LGG	DFS	Tertile	All	0.278	0.440	.001	21	view →
KIRP	OS	Tertile	All	0.197	0.711	.001	15	view →
HNSC	DFS	Tertile	II,III,IV	0.454	0.334	.033	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

LINC01878–LUAD (DFS)

Open the LUAD breakdown →